Latest editorial
GOVERNMENT deals with two US pharmaceutical companies to buy 90 million advance doses of potential coronavirus vaccines undermines fair global access to the drug, campaigners have said.
The two separate deals announced today for in-development vaccines from Novavax (60 million doses) and Janssen (30m doses) were struck on a Britain-first basis.
Under the agreement with Janssen, the pharma subsidiary of Johnson & Johnson, the government can purchase 22 million more doses of the vaccine if required.
The US blockade of Cuba raises risks of a new global pandemic, experts warn at Unison conference
1943-2025: How one man’s unfinished work reveals the lethal lie of ‘colour-blind’ medicine
Politicians who continue to welcome contracts with US companies without considering the risks and consequences of total dependency in the years to come are undermining the raison d’etre of the NHS, argues Dr JOHN PUNTIS